{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:28:11Z","timestamp":1649165291288},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00106-015-0058-x","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T04:55:00Z","timestamp":1441083300000},"page":"649-660","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impfungen in der Pneumologie"],"prefix":"10.1007","volume":"63","author":[{"given":"H. M.","family":"Lode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Stahlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"58_CR1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0029-1215037","volume":"63","author":"G H\u00f6ffken","year":"2009","unstructured":"H\u00f6ffken G, Lorenz J, Kern W et al (2009) S3-Leitlinie f\u00fcr Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfekten sowie ambulant erworbener Pneumonie. Pneumologie 63:613\u2013652","journal-title":"Pneumologie"},{"issue":"Suppl 6","key":"58_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2011.03602.x","volume":"17","author":"M Woodhead","year":"2011","unstructured":"Woodhead M, Blasi F, Ewig G et al (2011) Guidelinies for the management of adult lower respiratory tract infections. Clin Microbiol Infect 17(Suppl 6):1\u201324","journal-title":"Clin Microbiol Infect"},{"key":"58_CR3","volume-title":"Global strategy for the diagnosis and management, and prevention of COPD","author":"RR Roisin","year":"2011","unstructured":"Roisin RR, Vestbo J, Anzueto A et al (2011) Global strategy for the diagnosis and management, and prevention of COPD. http:\/\/www.goldcopd.org"},{"key":"58_CR4","first-page":"313","volume":"34","author":"Robert-Koch-Institut","year":"2013","unstructured":"Robert-Koch-Institut (2013) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am RKI\/Stand August 2013. Epidemiol Bull 34:313\u2013344","journal-title":"Epidemiol Bull"},{"key":"58_CR5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00103-013-1693-6","volume":"56","author":"C Poethko","year":"2013","unstructured":"Poethko C, Schmitz R (2013) Impfstatus von Erwachsenen in Deutschland. Bundesgesundheitsblatt 56:845\u2013857","journal-title":"Bundesgesundheitsblatt"},{"key":"58_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12325-013-0025-4","volume":"30","author":"H Lode","year":"2013","unstructured":"Lode H, Ludwig E, Kassianos G (2013) Pneumococcal infection \u2013 low awareness as a potential barrier to vaccination: results of a European survey. Adv Ther 30:387\u2013405","journal-title":"Adv Ther"},{"key":"58_CR7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takenchi O (2006) Pathogen recognition and innate immunity. Cell 124:783\u2013801","journal-title":"Cell"},{"key":"58_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0029-1220211","volume":"134","author":"AH Dalpke","year":"2009","unstructured":"Dalpke AH (2009) Immunologische Rationale von Impfungen. Dtsch Med Wochenschr 134:561\u2013564","journal-title":"Dtsch Med Wochenschr"},{"key":"58_CR9","unstructured":"Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness \u2013 United States (2013) MMWR 62:119\u2013123"},{"key":"58_CR10","first-page":"793","volume":"110","author":"P Wutzler","year":"2013","unstructured":"Wutzler P, Hardt R, Knuf M, Wahle K (2013) Zielgruppenspezifische Wahl der Impfstoffe bei Grippeimpfung. Dtsch Arztebl 110:793\u2013798","journal-title":"Dtsch Arztebl"},{"key":"58_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2010.08.028","volume":"28","author":"RB Belske","year":"2010","unstructured":"Belske RB (2010) The need for quadrivalent vaccine against seasonal influenza. Vaccine 28:45\u201350","journal-title":"Vaccine"},{"key":"58_CR12","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1016\/j.vaccine.2007.02.045","volume":"25","author":"V Baldo","year":"2007","unstructured":"Baldo V, Baldovin T, Floreani A et al (2007) MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18\u201360 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine 25:3955\u20133961","journal-title":"Vaccine"},{"key":"58_CR13","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1016\/j.vaccine.2007.08.039","volume":"25","author":"J Puig-Barber\u00e0","year":"2007","unstructured":"Puig-Barber\u00e0 J, Diez-Domingo J, Varea AB et al (2007) MF59-adjuvanted subunit influenza vaccine in preventing hospitalisation for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 25:7310\u20137321","journal-title":"Vaccine"},{"key":"58_CR14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/aje\/kws313","volume":"176","author":"S Mannino","year":"2012","unstructured":"Mannino S, Villa M, Apolone G et al (2012) Effectiveness of adjuvanted influenza vaccination in elderly subjects in Northern Italy. Am J Epidemiol 176:527\u2013533","journal-title":"Am J Epidemiol"},{"key":"58_CR15","first-page":"CD002733","volume":"1","author":"PJ Poole","year":"2006","unstructured":"Poole PJ, Chacko E, Wood-Baker RW et al (2006) Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 1:CD002733","journal-title":"Cochrane Database Syst Rev"},{"key":"58_CR16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","volume":"12","author":"MT Osterholm","year":"2012","unstructured":"Osterholm MT, Kelley NS, Sommer A et al (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12:36\u201344","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"58_CR17","doi-asserted-by":"crossref","first-page":"20389","DOI":"10.2807\/ese.18.05.20389-en","volume":"18","author":"RG Pebody","year":"2013","unstructured":"Pebody RG, Andrews N, Mc Menamin J et al (2013) Vaccine effectiveness of 201\/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the UK: evidence of waning intra-seasonal protection. Euro Surveill 18(5):20389","journal-title":"Euro Surveill"},{"key":"58_CR18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vaccine.2014.06.052","volume":"33","author":"EA Belongia","year":"2014","unstructured":"Belongia EA, Sundaram ME, Mc Clure DL et al (2014) Waning vaccine protection against influenza A (H3 N2) illness in children and older adults during a single season. Vaccine 33:246\u2013251","journal-title":"Vaccine"},{"key":"58_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","volume":"64","author":"N Pica","year":"2013","unstructured":"Pica N, Palese P (2013) Toward an universal influenza virus vaccine: prospects and challenges. Annu Rev Med 64:189\u2013202","journal-title":"Annu Rev Med"},{"key":"58_CR20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0032-1310103","volume":"66","author":"MW Pletz","year":"2012","unstructured":"Pletz MW, von Baum H, van der Linden M, Welte T et al (2012) The burden of pneumococcal pneumonia \u2013 experience of the German competence network CAPNETZ. Pneumologie 66:470\u2013475","journal-title":"Pneumologie"},{"key":"58_CR21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","volume":"67","author":"T Welte","year":"2012","unstructured":"Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71\u201379","journal-title":"Thorax"},{"key":"58_CR22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thx.2008.109785","volume":"64","author":"S Ewig","year":"2009","unstructured":"Ewig S, Birkner N, Strauss R et al (2009) New perspectives on CAP in 388.406 patients. Results from a nationwide mandatory performance measurement programme in health care quality. Thorax 64:1062\u20131069","journal-title":"Thorax"},{"key":"58_CR23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","volume":"68","author":"A Torres","year":"2013","unstructured":"Torres A, Peetermans WE, Vilgi G et al (2013) Risk factors for CAP in adults in Europe: a literature review. Thorax 68:1057\u20131065","journal-title":"Thorax"},{"key":"58_CR24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00391-014-0650-9","volume":"47","author":"G F\u00e4tkenheuer","year":"2014","unstructured":"F\u00e4tkenheuer G, Kwetkat A, Pletz MW et al (2014) Pr\u00e4vention im Alter: Stellungnahme zur Pneumokokkenimpfung. Z Gerontol Geriatr 47:302\u2013309","journal-title":"Z Gerontol Geriatr"},{"key":"58_CR25","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1055\/s-0034-1370126","volume":"139","author":"M Imohl","year":"2014","unstructured":"Imohl M, von der Linden M (2014) Invasive Pneumokokken-Erkrankungen in Deutschland im Zeitalter der Pneumokokken-Konjugat-Impfung. Dtsch Med Wochenschr 139:1346\u20131351","journal-title":"Dtsch Med Wochenschr"},{"key":"58_CR26","volume-title":"Empfehlungen der S\u00e4chsischen Impfkommission zur Durchf\u00fchrung von Schutzimpfungen im Freistaat Sachsen. Stand: 01.01.2014","author":"S\u00e4chsische Impfkommission","year":"2014","unstructured":"S\u00e4chsische Impfkommission (2014) Empfehlungen der S\u00e4chsischen Impfkommission zur Durchf\u00fchrung von Schutzimpfungen im Freistaat Sachsen. Stand: 01.01.2014. http:\/\/www.slaek.de\/de\/03\/36impfen\/pdf\/E1%5F2014pdf . Zugegriffen: 02. Mai 2014"},{"issue":"Suppl 1","key":"58_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12320","volume":"19","author":"P Durando","year":"2013","unstructured":"Durando P, Faust SN, Fletscher M et al (2013) Experience with pneumococcal polysaccharide conjugate vaccine in children and adults. Clin Microbiol Infect 19(Suppl 1):1\u20139","journal-title":"Clin Microbiol Infect"},{"key":"58_CR28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","volume":"46","author":"A Roux De","year":"2008","unstructured":"De Roux A, Schmoele-Thoma B, Siber GR et al (2008) Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccine in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 46:1015\u20131023","journal-title":"Clin Infect Dis"},{"key":"58_CR29","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jis212","volume":"205","author":"EA Clutterbuck","year":"2012","unstructured":"Clutterbuck EA, Lazarus R, Yu LM et al (2012) Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J Infect Dis 205:1408\u20131416","journal-title":"J Infect Dis"},{"key":"58_CR30","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1055\/s-0033-1343340","volume":"138","author":"MW Pletz","year":"2013","unstructured":"Pletz MW (2013) Pneumokokkenimpfung. Dtsch Med Wochenschr 138:1734\u20131736","journal-title":"Dtsch Med Wochenschr"},{"key":"58_CR31","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","volume":"30","author":"NJ Andrews","year":"2012","unstructured":"Andrews NJ, Waight PA, George AC et al (2012) Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. Vaccine 30:6802\u20136808","journal-title":"Vaccine"},{"key":"58_CR32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM et al (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201:32\u201341","journal-title":"J Infect Dis"},{"key":"58_CR33","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","volume":"31","author":"LA Jackson","year":"2013","unstructured":"Jackson LA, Gurtmann A, Van Cleeff M (2013) Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine 31:3577\u20133584","journal-title":"Vaccine"},{"key":"58_CR34","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.vaccine.2013.05.010","volume":"31","author":"LA Jackson","year":"2013","unstructured":"Jackson LA, Gurtmann A, Rice K et al (2013) Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 31:3585\u20133593","journal-title":"Vaccine"},{"key":"58_CR35","unstructured":"Bonten M, Bolkenbaas M, Huijtss et al (2014) Community acquired pneumonia immunisation trial in adults (CAPiTA). 9th International Symposium Pneumococci and Pneumococcal Diseases (March 9\u201313, 2014, Hydrabad, India): Presentation 0541"},{"key":"58_CR36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/ajt.12073","volume":"13","author":"American College for Immunization Practices (ACIP)","year":"2013","unstructured":"American College for Immunization Practices (ACIP) (2013) Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of Advisory Committee on Immunization Practices. Am J Transplant 13:232\u2013235","journal-title":"Am J Transplant"},{"key":"58_CR37","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.vaccine.2014.02.002","volume":"32","author":"RN Greenberg","year":"2014","unstructured":"Greenberg RN, Gurtman A, Frenck RW et al (2014) Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-na\u00efve adults 60\u201364 years of age. Vaccine 32:2364\u20132374","journal-title":"Vaccine"},{"key":"58_CR38","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(00)04237-9","volume":"357","author":"B Christenson","year":"2001","unstructured":"Christenson B, Lundbergh P, Hedlund J et al (2001) Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 357:1008\u20131011","journal-title":"Lancet"},{"key":"58_CR39","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1016\/j.vaccine.2011.05.031","volume":"29","author":"TF Schwarz","year":"2011","unstructured":"Schwarz TF, Flamaing J, R\u00fcmke HC et al (2011) A randomized double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged >\u200965 years. Vaccine 29:5195\u20135202","journal-title":"Vaccine"},{"key":"58_CR40","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","volume":"356","author":"DW Kimberlin","year":"2007","unstructured":"Kimberlin DW, Whitley RF (2007) Varicella-Zoster vaccine for the prevention of herpes zoster. N Engl J Med 356:1338\u20131343","journal-title":"N Engl J Med"},{"key":"58_CR41","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR et al (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271\u20132284","journal-title":"N Engl J Med"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-015-0058-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-015-0058-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-015-0058-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T21:54:02Z","timestamp":1567115642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-015-0058-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1007\/s00106-015-0058-x","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}